Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review

Martine Bocchini(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Massimiliano Mazza(Istituti di Ricovero e Cura a Carattere Scientifico)
Frontiers in Oncology
May 27, 2020
Cited by 48


Related Papers

Is PML a Tumor Suppressor?
|Frontiers in Oncology|2013|31